Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Female Breast Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05143970
What this trial is testing

First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors

Who this might be right for
Metastatic CancerMetastatic Breast CancerMetastatic Pancreatic Cancer+6 more
Institut Paoli-Calmettes 27
Not applicableStudy completedNCT04442035
What this trial is testing

5-element Music Therapy on Patients With Breast Cancer

Who this might be right for
Breast Cancer FemaleQuality of LifeDepression, Anxiety
Guangzhou University of Traditional Chinese Medicine 64
Early research (Phase 1)Ended earlyNCT04315233
What this trial is testing

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

Who this might be right for
Metastatic Breast CancerRecurrent Ovarian Carcinoma
University of Utah 12
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableStudy completedNCT01716247
What this trial is testing

Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer

Who this might be right for
Women at Increased Risk for Developing Breast Carcinoma
Memorial Sloan Kettering Cancer Center 1,000
Not applicableStudy completedNCT03115658
What this trial is testing

Physical Activity and First Degree Female Relatives of Breast Cancer Patients

Who this might be right for
FemaleFirst-degree Relative With Breast Cancer
University of California, San Diego 27
Early research (Phase 1)Study completedNCT02482311
What this trial is testing

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Who this might be right for
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
AstraZeneca 92
Testing effectiveness (Phase 2)Ended earlyNCT04278144
What this trial is testing

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Who this might be right for
HER2-positive Solid TumorsHER2-positive Breast CancerHER2-positive Colorectal Cancer+2 more
Bolt Biotherapeutics, Inc. 175
Testing effectiveness (Phase 2)Study completedNCT06703593
What this trial is testing

Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
Breast Cancer Female
British University In Egypt 80
Not applicableStudy completedNCT04817709
What this trial is testing

Development of a Patient Decision Aid for Women Considering Breast Reconstruction

Who this might be right for
Breast Carcinoma
M.D. Anderson Cancer Center 126
Not applicableEnded earlyNCT03850171
What this trial is testing

Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study

Who this might be right for
Breast Neoplasm FemaleLymphomaCardiotoxicity+2 more
Insel Gruppe AG, University Hospital Bern 57
Not applicableWithdrawnNCT03005860
What this trial is testing

Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serum Biomarkers and on PBMCs in Breast Cancer Surgery

Who this might be right for
Female Breast Cancer
Tata Memorial Centre
Testing effectiveness (Phase 2)Looking for participantsNCT07447050
What this trial is testing

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric (Stomach) Cancer+7 more
University of California, Irvine 24
Early research (Phase 1)Study completedNCT01155258
What this trial is testing

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Extensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more
University of Southern California 19
Early research (Phase 1)Active Not RecruitingNCT05082259
What this trial is testing

ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab

Who this might be right for
Advanced CancerCervical CancerTriple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 61
Not applicableNot Yet RecruitingNCT07648810
What this trial is testing

Comparison Immune Response in Paravertebral and Erector Spinal Plane Block in Breast Cancer Patients

Who this might be right for
Breast Cancer - Female
Clinical Hospital Center Rijeka 56
Not applicableStudy completedNCT00899548
What this trial is testing

DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 182
Testing effectiveness (Phase 2)Study completedNCT02650193
What this trial is testing

The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.

Who this might be right for
Non-metastatic Breast Cancer
Pfizer 25
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Not applicableActive Not RecruitingNCT03121248
What this trial is testing

Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years

Who this might be right for
Breastcancer
University Hospital, Ghent 144
Next Page